Login   |  Users Online: 3200 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Search Article 
  
Advanced search 
   Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts
CLINICAL RESEARCH
Year : 2014  |  Volume : 35  |  Issue : 1  |  Page : 15-21

Efficacy of Triphaladi Avaleha on Beejadushtijanya Pandu (Thalassemia)


1 Department of Kaumarabhritya, G. J. Patel Institute of Ayurveda Studies and Research, New Vallabh Vidyanagar, Anand, India
2 Department of Kaumarabhritya, Institute for Post Graduate Teaching and Research in Ayurveda, Jamnagar, Gujarat, India

Correspondence Address:
Abhishek Y Patalia
Block No. 5, 2nd Floor, "RAJRATNA" Appt, Ranjitnagar Main Road, Jamnagar - 361 001, Gujarat
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-8520.141898

Rights and Permissions

Background: Hemoglobinopathies constitute a major public health problem internationally, particularly in the developing world as it has the least resources for coping with the problem. Thalassemia is an inherited single-gene autosomal recessive disorder of the Red Blood Corpuscles (RBCs). Life becomes miserable due to blood transfusion every fortnight, recurrent infections, stunted growth, problems of iron overload, splenectomy, and decreased school performance. Nearly Rs. 1000 Crore is being spent in the treatment of thalassemia per annum. Aim: To evaluate the efficacy of Triphaladi Avaleha in Beejadushtijanya Pandu (thalassemia). Materials and Methods: Total 32 patients of age group 1-15 years were registered and randomly divided into two groups. Group A (test drug treated group) and Group B (control group). In Group A, Triphaladi Avaleha was given with Godugdha, and in Group B, Deferiprone was administered. Assessment was done based on the subjective and objective parameters after 12 weeks of treatment, with a follow-up of 8 weeks. Results: The trial drug proved better than the standard control in Paandutaa and Sandhishoola at a highly significant level and in Jwara, Akshikootashotha and Pindikodweshtana at a significant level. In Group A, five patients (38.46%) showed maximum improvement, five patients (38.46%) showed moderate improvement, two patients (15.38%) had mild improvement. Conclusion: Triphaladi Avaleha has various properties which help to relieve the signs and symptoms of the disease, as well as decrease the iron overload.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3099    
    Printed50    
    Emailed0    
    PDF Downloaded388    
    Comments [Add]    

Recommend this journal